Suppr超能文献

慢性便秘的流行病学与负担

Epidemiology and burden of chronic constipation.

作者信息

Sanchez Maria Ines Pinto, Bercik Premysl

机构信息

McMaster University, Hamilton, Ontario, Canada.

出版信息

Can J Gastroenterol. 2011 Oct;25 Suppl B(Suppl B):11B-15B. doi: 10.1155/2011/974573.

Abstract

Chronic constipation is an important component of clinical gastroenterology practice worldwide. Based on the definition, either self-reported or using Rome criteria, chronic constipation can affect from 2% to 27% of the population. Constipation is physically and mentally troublesome for many patients, and can significantly interfere with their daily living and well-being. Although only a proportion of patients with constipation seek medical care, most of them use prescribed or over-the-counter medication to improve their condition. The health care costs of constipation are significant as evidenced by the hundreds of million dollars spent yearly on laxatives alone. Because constipation is more common in older patients and life expectancy is increasing, an increase in the prevalence of constipation is expected in the years to come, with the associated impact on quality of life and socioeconomic burden.

摘要

慢性便秘是全球临床胃肠病学实践的一个重要组成部分。根据定义,无论是自我报告还是使用罗马标准,慢性便秘在人群中的患病率可达2%至27%。便秘给许多患者带来身体和精神上的困扰,并会严重干扰他们的日常生活和幸福感。虽然只有一部分便秘患者寻求医疗帮助,但他们中的大多数人会使用处方药或非处方药来改善病情。仅每年在泻药上花费的数亿美元就证明了便秘的医疗成本是巨大的。由于便秘在老年患者中更为常见,且预期寿命在增加,预计未来几年便秘的患病率将会上升,并对生活质量和社会经济负担产生相关影响。

相似文献

1
Epidemiology and burden of chronic constipation.慢性便秘的流行病学与负担
Can J Gastroenterol. 2011 Oct;25 Suppl B(Suppl B):11B-15B. doi: 10.1155/2011/974573.
10
Economic aspects of pharmacotherapy for chronic constipation.慢性便秘药物治疗的经济学方面
Pharmacoeconomics. 1995 Jan;7(1):14-24. doi: 10.2165/00019053-199507010-00003.

引用本文的文献

9
Real World Evidence of User Experience with Microenemas for Relief of Constipation.微灌肠剂缓解便秘的用户体验的真实世界证据。
Drugs Real World Outcomes. 2024 Dec;11(4):659-667. doi: 10.1007/s40801-024-00444-z. Epub 2024 Sep 8.

本文引用的文献

2
Prescribing patterns for the outpatient treatment of constipation in the United States.美国门诊治疗便秘的处方模式。
Dig Dis Sci. 2010 Dec;55(12):3514-20. doi: 10.1007/s10620-010-1196-3. Epub 2010 Apr 17.
3
Systematic review: impact of constipation on quality of life in adults and children.系统评价:便秘对成人和儿童生活质量的影响。
Aliment Pharmacol Ther. 2010 May;31(9):938-49. doi: 10.1111/j.1365-2036.2010.04273.x. Epub 2010 Feb 20.
4
Impact of functional gastrointestinal disorders on survival in the community.功能性胃肠病对社区人群生存的影响。
Am J Gastroenterol. 2010 Apr;105(4):822-32. doi: 10.1038/ajg.2010.40. Epub 2010 Feb 16.
5
Emerging drugs for chronic constipation.用于慢性便秘的新型药物。
Expert Opin Emerg Drugs. 2009 Sep;14(3):493-504. doi: 10.1517/14728210903146890.
7
[Quality of life specific questionnaire for constipated patients: development and validation of CVE-20].
Med Clin (Barc). 2008 Sep 27;131(10):371-7. doi: 10.1016/s0025-7753(08)72285-1.
8
Functional gastrointestinal disorders as a public health problem.功能性胃肠病作为一个公共卫生问题。
Neurogastroenterol Motil. 2008 May;20 Suppl 1:121-9. doi: 10.1111/j.1365-2982.2008.01097.x.
9
Cumulative incidence of chronic constipation: a population-based study 1988-2003.慢性便秘的累积发病率:一项基于人群的1988 - 2003年研究
Aliment Pharmacol Ther. 2007 Dec;26(11-12):1521-8. doi: 10.1111/j.1365-2036.2007.03540.x. Epub 2007 Oct 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验